Early Breast Cancer: LHRH Agonists Show Considerable Promise
Friday, October 10, 2008 - 11:28
in Health & Medicine
Women who have had early stage breast cancer surgically removed, and whose tumor cells are stimulated by the hormone estrogen, can benefit from taking luteinizing hormone releasing hormone antagonists, a Cochrane systematic review has concluded. This medication may be taken alone or alongside the use of tamoxifen.